Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-07

Clinical Trial Update: Evaluate the Accuracy of the NBM200 for Noninvasive Hemoglobin Measurements on Obstetric/Gynecological Patients

View source ↗

Summary

A clinical trial evaluating the accuracy of the NBM200 noninvasive hemoglobin monitor in obstetric/gynecological patients with anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NBM200 (Noninvasive hemoglobin monitor)

Snippet

Sponsor: OrSense, Ltd. | Conditions: Anemia | Status: UNKNOWN